Welcome to
Lunatum Biotech
Your preclinical CRO for orthopedic research models and gene therapy
Your preclinical CRO for orthopedic research models and gene therapy
Attention molecular therapy and gene delivery system developers seeking novel therapeutic avenues with significant unmet needs: Explore the promising realm of musculoskeletal medicine with Lunatum Biotech! In a market ripe with opportunities and a pressing demand for effective molecular and gene therapy treatments, our seasoned and specialized scientists stand ready to collaborate with you. Together, we'll identify compelling disease indications for your technology and pioneer life-changing therapies for patients battling debilitating musculoskeletal conditions. Join us in shaping the future of medicine and making a tangible difference in patients' lives.
Lunatum Biotech offers a comprehensive solution for the preclinical evaluation (including orthopedic research models) of pioneering therapy approaches, serving as your premier partner in advancing medical progress. With expertise spanning orthopedics and sports medicine, trauma and reconstructive surgery, dentistry and oral surgery, and rheumatology, we are committed to addressing the unmet needs of the pharmaceutical and biotech industry. At Lunatum, we aim to play a pivotal role in propelling the field of musculoskeletal therapies forward.
At Lunatum Biotech, we prioritize direct collaboration between our clients and seasoned lead scientists, ensuring responsive and transparent communication at every step of the project. Our hallmark is delivering scientific excellence promptly and within budget, setting us apart in the industry. With a team of highly motivated scientists who deeply comprehend your requirements, we are dedicated to advancing both your scientific goals and commercial success. Partner with Lunatum Biotech for a seamless journey towards achieving your objectives.
Lunatum Biotech is your reliable and innovative preclinical CRO and partner for preclinical research and development in the field of molecular musculoskeletal medicine and gene therapy. Our scientists use optimized techniques and work protocols for the isolation and in-depth analysis of on-target and off-target cells. Using a variety of innovative in-vitro modeling systems and in-vivo orthopedic research models, we provide crucial preclinical insights to companies working towards developing targeted drugs for the rapidly expanding orthopedic therapy market.
Selected models (but not limited to):
Our array of services encompasses:
We possess unparalleled expertise regarding the following target tissues/organs:
We employ a variety of experimental methods,
such as:
Contact us for further details regarding our continuously expanding services.
The disorders listed below provide valuable insight into the numerous unmet treatment needs within musculoskeletal diseases. Please don't hesitate to contact us for in-depth discussions about target diseases, areas of research interests, and how Lunatum Biotech can offer support in developing cures for these conditions. We are deeply committed to collaborating with you to make significant strides in the field of musculoskeletal medicine.
Osteoporosis, Osteogenesis Imperfecta (OI), Fibrous Dysplasia, Hypophosphatasia, Fibrodysplasia Ossificans Progressiva (FOP), Multiple Epiphyseal Dysplasia (MED), Osteonecrosis, bone tumors, bone metastasis, bone fractures, osseous non-unions, bone defects
Osteoarthritis, cartilage defects, osteochondral defects, Diastrophic Dysplasia
Tendon ruptures, Tendinitis, Tendinopathy, chronic tendon degeneration, ligament tears
Osteoarthritis, Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis
Sarcopenia, Duchenne Muscular Dystrophy, Myasthenia Gravis, Spinal Muscular Atrophy, Polymyalgia Rheumatica, Polymyositis, muscle injuries
Intervertebral Disc Disease
Chief Executive Officer and founder; post-doctoral training and Instructor at Harvard Medical School; Head of Orthopedic Regenerative Medicine at the University of Munich LMU; Visiting Scientist at MIT; 25 + years of experience in musculoskeletal gene medicine.
Medical Director and co-founder; post-doctoral training at Harvard Medical School; Orthopedic Surgeon; 20 + years of experience in orthopedic gene therapy.
Chief Scientific Officer; post-doctoral training at Harvard Medical School; Assistant Professor at Einstein College of Medicine; 25 + years of experience in molecular musculoskeletal medicine.
Please send us a message or call us!
Lunatum Biotech´s phone number:
(+1) 781 518 8894
Lunatum Biotech´s Email:
Lunatum Biotech´s address:
100 Cummings Center, Suite 451C
Beverly, MA 01915
USA